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Abstract
Background: Clear cell sarcoma (CCS) is a rare malignant soft-tissue neoplasm that displays melanocytic markers
and exhibits striking histopathological features. The tumour has a predilection for the lower extremities and rarely
presents in the mediastinum.
Case presentation: We present a case of primary mediastinal CCS in a 57-year-old man. Computer tomography
(CT) revealed a 12 × 12 × 7.5 cm mass in the anterior mediastinum. Microscopically, the tumour mainly consisted of
epithelioid cells with oval vesicular nuclei and eosinophilic cytoplasm. Immunohistochemically, the tumour was
positive for human melanoma black 45 (HMB-45) and vimentin but negative for S-100 and Melan-A. Fluorescence in
situ hybridisation (FISH) showed a translocation involving the EWSR1 gene region.
Conclusion: This report will illustrate that the mediastinum is a potential site for primary CCS and FISH plays an
important role in making a conclusive diagnosis.
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Background
CCS is a rare aggressive sarcoma accounting for only 1%
of soft-tissue sarcoma. It usually occurs in adolescents
and young adults. The first description of a case of CCS
is attributed to Enzinger in 1965, which called it a “ma-
lignant melanoma of soft parts” due to its melanocytic
differentiation [1]. The tumour often arises in deep soft
tissue of the lower extremities, especially the region of
the foot and ankle, in association with fascia, tendons, or
aponeuroses. It is rarely located in visceral sites [2–7].
Common tumours in adults that occur in the anterior
mediastinum are thymomas, lymphomas, and germ cell
tumours. Other soft-tissue tumours that arise in the anter-
ior mediastinum can include leiomyosarcoma, malignant
peripheral nerve sheath tumour, liposarcoma, synovial
sarcoma, angiosarcoma, and extraskeletal osteosarcoma,
among others. A primary CCS in the anterior mediasti-
num is extremely rare. The present study reports an
unusual case of CCS in the mediastinum, confirmed by
FISH analysis and immunohistochemical study.
Case presentation
A 57-year-old man was admitted to our hospital with
complaints of a 1-month history of chest distending
pain. He had no history of cutaneous malignancy. On
admission, a chest CT revealed a giant lobulated mass
with uneven density approximately 12 × 12 × 7.5 cm in
size occupying the anterior mediastinum (Fig. 1a and b).
There were no obvious calcification and fat density
shadows. The mass showed a slight heterogeneous en-
hancement on a contrast-enhanced CT scan. The serum
levels of tumour markers, namely alpha-fetoprotein
(AFP) and carcinoembryonic antigen (CEA), were within
normal limits. A median sternotomy was performed. A
giant circumscribed and partly encapsulated mass was
found attached to the right thymus. The tumour occu-
pied the anterior mediastinum and invaded the right
mediastinal pleura. Scattered 2- to 4-mm nodules were
found on the surface of the pericardium and the upper
lobe of the right lung.
Grossly, the mass was well-demarcated, measuring
10 × 10 × 5 cm in size and yellow-grey on the cut
surface. A massive necrosis was identified.
Histologically, the tumour demonstrated expansive
growth and infiltrated the adjacent lung tissue (Fig. 2a).
The tumour mainly consisted of epithelioid or polygonal
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cells arranged in sheets (Fig. 2b). Clusters of tumour
cells were set in a fibrous stroma (Fig. 2c). These tumour
cells had oval vesicular nuclei with prominent eosino-
philic nucleoli and palely eosinophilic cytoplasm
(Fig. 2d). A large necrosis was found (Fig. 2e). A propor-
tion of the cells contained melanin (Fig. 2f ).
Immunohistochemical studies showed a strong but
diffuse distribution of the markers vimentin (Fig. 3a) and
HMB-45 (Fig. 3b). These cells were negative for Melan-A,
S-100, CD117, CK19, CD56, CD99, synaptophysin, chro-
mogranin A, CD34, TTF-1, CD2, CD5, CD20, and
ALKp80. The Ki-67 index was about 30% (Fig. 3c).
Fig. 1 Chest computed tomography (CT). a, b The tumour mass was located in the anterior mediastinum with heterogeneous enhancement
Fig. 2 a The tumour demonstrated expansive growth and infiltrated into the adjacent lung tissue (magnification × 40). b The tumour mainly
consisted of epithelioid or polygonal cells arranged in sheets (magnification × 100). c Clusters of tumour cells were set in a fibrous stroma
(magnification × 200). d Tumour cells have eosinophilic cytoplasm and oval vesicular nuclei with prominent eosinophilic nucleoli (magnification × 400).
e A large necrosis was found (magnification × 100). f There were some melanin-producing tumour cells (magnification × 100)
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Dual colour interphase fluorescence in situ hybridisa-
tion utilising the EWSR1 break-apart probe was per-
formed on a paraffin section. A clear separation of red
and green signals within a single cell was identified in
most cells, which demonstrated the presence of the
EWSR1 rearrangement (Fig. 3d). No BRAF mutation
was detected.
To date, 8 months after operation, the patient is well
and without evidence of a recurrence or metastasis.
Discussion
CCSs are a distinctive form of soft-tissue neoplasms
arising from the deeper soft tissues of the extremities in
90–95% of cases. They make up 1% of all soft-tissue
sarcomas and mainly affect young adults aged 20–40,
with a slight female bias. CCSs also arise in other rare
locations outside of the extremities, such as the kidney
[8], stomach [9], and scapula [10]. In the present case,
the mass was located in the anterior mediastinum.
Primary mediastinal CCSs are extremely rare. Of all
published studies on CCSs, there are only 2 reported
cases in the literature involving mediastinum [11, 12].
Morphologic appearances in both cases were similar to
cutaneous melanoma. The first case was a 59-year-old
woman with superior mediastinal involvement. The
tumour was 12 × 6 × 5 cm in size and the cut surface
showed a diffuse area of necrosis and cystic change.
Although the tumour cells showed an absence of
melanocytic differentiation, as demonstrated by the lack
of expression of markers such as HMB-45 and Melan-A,
FISH analysis showed EWS gene rearrangement. The
second patient was a 63-year-old man with a right upper
mediastinum tumour. The tumour was 8.5 × 5.5 × 5.5 cm
in size. Tumour cells were positive for HMB-45 and S-
100, but a gene analysis was not performed. Obviously,
our case is the first case of a CCS involving the mediasti-
num supported by demonstration of both EWSR1 gene
rearrangement and melanocytic differentiation.
Three cases of mediastinal CCSs, including our case,
shared some common characteristics, such as a tumour
size over 5 cm and a diffuse area of necrosis. Since the
mediastinum is the internal space in the thoracic cavity
between the lungs surrounded by loose connective
tissue, mediastinal tumours tend to grow very large.
These tumours produce few symptoms and therefore
are often detected at the later stage. With the in-
crease of tumour size, the central area of the tumour
is prone to develop necrosis as a result of an insuffi-
cient blood supply.
Mediastinal CCSs also have similar morphological
appearance. As indicated in our case, the tumour was
composed of epithelioid cells with ovoid vesicular nuclei
and eosinophilic cytoplasm. These cells infiltrated the
adjacent lung tissue, showing an aggressive growth pat-
tern. CCS is supposed to derive from neural crest cells
and often shows melanocytic differentiation, which is
confirmed by the expressions of S-100, HMB-45, and
Melan-A. These markers are helpful for distinguishing
CCSs from other types of soft tumours. In our case, the
tumour cells were positive for HMB-45. However, we
were unable to identify either S-100 or Melan-A in
multiple sections of the tumour. Due to the inconsistent
expression of melanocytic markers and its unusual site,
more tumours should be rules out before making a
diagnosis of CCS.
In patients without cutaneous involvement and a
history of melanoma, distinguishing CCS from meta-
static malignant melanoma may have diagnostic diffi-
culties because CCS shares striking histological and
immunohistochemical similarities with cutaneous mel-
anoma. Fortunately, molecular genetic characterisation
of CCS has been shown to be specific for t(12;22) trans-
location, which has not yet been identified in melanoma
[13, 14]. Previous molecular studies showed that cutane-
ous melanoma has frequent BRAF mutations, but not in
CCS [15, 16]. Therefore, we strengthened the diagnosis
by using FISH analysis, which demonstrated an un-
equivocal EWSR1 gene rearrangement and lack of BRAF
mutation. Other potential differential diagnoses include
thymic carcinoma, lymphoma, neuroendocrine tumours,
germ cell tumours, and other types of sarcomas. A
careful microscopic examination and a panel of immu-
nohistochemistry can rule out most of these diagnoses.
Sometimes the distinction between the tumours may be
Fig. 3 a Immunohistochemical examination showed positive
expression of vimentin (magnification × 400). b Immunohistochemical
examination showed positive expression of HMB45 (magnification × 400).
c Approximately 30% of the tumour cells were positive for the
proliferation marker (Ki67, magnification × 200). d Dual color
interphase fluorescence in situ hybridisation utilizing the EWSR1
break-apart probe. Split red and green signals within a single cell
demonstrated the presence of a EWSR1 rearrangement (indicated
by white arrows)
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difficult only by examining morphological features and
an immunohistochemical study; therefore, a molecular
genetics study is necessary for the correct diagnosis.
CCS has an aggressive behaviour. Poor prognosis of
CCS is closely related to tumour size > 5 cm and the
presence of necrosis, metastasis, and local recurrence.
Although the patient has not shown any evidence of
tumour recurrence or metastasis during the follow-up
period for 8 months, the tumour’s diameter > 5 cm and
massive necrosis indicated a poor prognosis.
Conclusions
In conclusion, we report an extremely rare mediastinal
CCS, a high grade of soft-tissue sarcoma with a distinct
molecular gene rearrangement and with morphological
features. The present case demonstrates that the medias-
tinum is a possible site of CCS and that a molecular
genetics study is necessary for the correct diagnosis.
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